CIDARA THERAPEUTICS INC (CDTX)
US1717572069 - Common Stock
CIDARA THERAPEUTICS INC
NASDAQ:CDTX (1/3/2025, 8:26:23 PM)
26.62
-0.68 (-2.49%)
Company Profile
Cidara Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in San Diego, California and currently employs 69 full-time employees. The company went IPO on 2015-04-15. Cidara Therapeutics, Inc. is a biotechnology company. The firm is developing targeted immunotherapies designed for patients facing serious diseases. The Company’s portfolio comprises various treatment and prevention paradigms, including drug-Fc conjugate (DFC) from its Cloudbreak platform targeting oncologic, viral and autoimmune diseases. The firm is focused on advancing Cloudbreak development programs, including its lead oncology candidate, CBO421, as well as advancing other pipeline assets. CBO421 is a development candidate targeting CD73 for the treatment of solid tumors. Its advanced DFC program is CD388, a highly potent antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which is in Phase I and Phase IIa clinical trials. Its additional programs target multiple autoimmune indications.
Company Info
CIDARA THERAPEUTICS INC
6310 Nancy Ridge Dr Ste 101
San Diego CALIFORNIA 92121
P: 18587526170
CEO: Jeffrey Stein
Employees: 69
Website: https://www.cidara.com/
CDTX News
a month ago - Cidara Therapeutics, Inc. Cidara Therapeutics Completes Enrollment of Phase 2b NAVIGATE Trial Evaluating CD388 for Prevention of Seasonal InfluenzaSAN DIEGO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform...
a month ago - Cidara Therapeutics, Inc. Cidara Therapeutics Announces $105 Million Private PlacementFinancing led by new investor, Venrock Healthcare Capital Partners, with significant participation by new and existing life sciences-focused investors...
2 months ago - Cidara Therapeutics, Inc. Cidara Therapeutics to Participate in Evercore 7th Annual HealthCONx ConferenceSAN DIEGO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform...
2 months ago - Cidara Therapeutics, Inc. Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial ResultsSAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary...
2 months ago - Cidara Therapeutics, Inc. Cidara Therapeutics to Participate in Two Upcoming November Investor ConferencesSAN DIEGO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform...
3 months ago - Cidara Therapeutics, Inc. Cidara Therapeutics Announces Two Presentations on Drug-Fc Conjugate, CD388, at IDWeek 2024SAN DIEGO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform...
CDTX Twits
Here you can normally see the latest stock twits on CDTX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
